BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 16304673)

  • 1. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
    Rembratt A; Riis A; Norgaard JP
    Neurourol Urodyn; 2006; 25(2):105-9. PubMed ID: 16304673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?].
    ten Doesschate T; Reichert LJ; Claassen JA
    Tijdschr Gerontol Geriatr; 2010 Dec; 41(6):256-61. PubMed ID: 21229778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender difference in antidiuretic response to desmopressin.
    Juul KV; Klein BM; Sandström R; Erichsen L; Nørgaard JP
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1116-22. PubMed ID: 21367921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study.
    Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG
    J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis.
    Weatherall M
    Neurourol Urodyn; 2004; 23(4):302-5. PubMed ID: 15227644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns.
    Rembratt A; Norgaard JP; Andersson KE
    BJU Int; 2003 May; 91(7):642-6. PubMed ID: 12699476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia in elderly patients treated with desmopressin for nocturia: a review of a case series.
    Callréus T; Ekman E; Andersen M
    Eur J Clin Pharmacol; 2005 Jun; 61(4):281-4. PubMed ID: 15875172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of desmopressin in elderly patients in Denmark.
    Callréus T
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):995-8. PubMed ID: 17437326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of intranasal desmopressin in the treatment of nocturia due to nocturnal polyuria].
    Terada N; Arakaki R; Okada Y; Kitahara M; Kaneko Y; Omori K; Nishimura K
    Hinyokika Kiyo; 2005 Mar; 51(3):151-4. PubMed ID: 15852666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia.
    Juul KV; Malmberg A; van der Meulen E; Walle JV; Nørgaard JP
    BJU Int; 2017 May; 119(5):776-784. PubMed ID: 27862898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?
    Thumfart J; Roehr CC; Kapelari K; Querfeld U; Eggert P; Müller D
    J Urol; 2005 Jul; 174(1):294-8; discussion 298. PubMed ID: 15947670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observations of the effect of antidiuretic hormone on nocturia in elderly men.
    Ho DR; Lin WY; Wu CF; Shee JJ; Huang YC; Chen CS
    BJU Int; 2005 Dec; 96(9):1310-3. PubMed ID: 16287451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experiences with desmopressin for long-term treatment of nocturia.
    Lose G; Mattiasson A; Walter S; Lalos O; van Kerrebroeck P; Abrams P; Freeman R
    J Urol; 2004 Sep; 172(3):1021-5. PubMed ID: 15311028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.
    Lose G; Lalos O; Freeman RM; van Kerrebroeck P;
    Am J Obstet Gynecol; 2003 Oct; 189(4):1106-13. PubMed ID: 14586363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP to prevent rapid correction in hyponatremia.
    Goldszmidt MA; Iliescu EA
    Clin Nephrol; 2000 Mar; 53(3):226-9. PubMed ID: 10749304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term durability of the response to desmopressin in female and male nocturia patients.
    Juul KV; Klein BM; Nørgaard JP
    Neurourol Urodyn; 2013 Apr; 32(4):363-70. PubMed ID: 22972524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical reasoning and decision making in practice: a 30-year-old man with unexplained coma].
    van den Born BJ; Hart W; Koopmans RP; Levi M
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1612-6. PubMed ID: 16078766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
    Robson WL; Leung AK; Norgaard JP
    J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
    Weiss JP; Herschorn S; Albei CD; van der Meulen EA
    J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.